Advertisement

Validation of contrast enhanced cine steady-state free precession and T2-weighted CMR for assessment of ischemic myocardial area-at-risk in the presence of reperfusion injury

  • Esben Søvsø Szocska Hansen
  • Steen Fjord Pedersen
  • Steen Bønløkke Pedersen
  • Hans Erik Bøtker
  • Won Yong KimEmail author
Original Paper
  • 44 Downloads

Abstract

The purpose of the study was to validate by histopathology, contrast enhanced cine steady-state free precession and T2-weighted CMR for the assessment of ischemic myocardial area-at-risk (AAR) in the presence of microvascular obstruction (MVO). Eleven anesthetized pigs underwent CMR 7 to 10 days post infarction. The area-at-risk was measured from T2-weighted fast spin echo (T2-STIR) and contrast-enhanced steady-state free precession magnetic resonance imaging (CE-SSFP) images using semi-automated algorithms based on a priori knowledge of perfusion territory. Also, late gadolinium enhancement (LGE) was performed to measure final infarct size (FIS). Histopathological comparison with Evans blue dye to define AAR and triphenyltetrazolium chloride to define FIS served as the reference. All infarcts demonstrated MVO on LGE images. Bland–Altman analysis showed no significant bias in AAR or myocardial salvage between T2-STIR and CE-SSFP or between CMR and histopathology. The mean differences ± 2SD from Bland–Altman analysis were: AAR: Evans Blue vs. T2-STIR [0.7%; + 13.5%; − 12.1%]; AAR: Evans Blue vs. CE-SSFP [0.1%; + 13.8%; − 13.7%]; AAR: T2-STIR vs. CE-SSFP [0.7%; + 6.2%; − 4.9%]; Salvage: Evans Blue − TTC vs. T2-STIR-LGE [0.8%; + 11.1%; − 9.6%]; Salvage: Evans Blue − TTC vs. CE-SSFP-LGE [0.1%; + 9.9%; − 9.6%]; Salvage: CE-SSFP-LGE vs. T2-STIR-LGE [0.7%; + 6.2%; − 4.9%]. Both T2-STIR and CE-SSFP sequences allow for unbiased quantification of AAR in the presence of ischemia/reperfusion injury when analysed by semi-automated algorithms. These experimental data, which was validated by histopathology, supports the use of CMR for the assessment of myocardial salvage during the subacute phase.

Keywords

Magnetic resonance imaging Myocardium at risk Edema Salvage Final infarct size 

Abbreviations

AAR

Area-at-risk

FIS

Final infarct size

CMR

Cardiovascular magnetic resonance

CE-SSFP

Contrast-enhanced steady-state free precession magnetic resonance imaging

ECG

Electrocardiogram

LV

Left ventricular

B-SSFP

Balanced-steady-state-free-precession

FOV

Field of view

TR

Repetition time

TE

Echo time

LGE

Late gadolinium enhancement

MVO

Microvascular obstruction

TTC

Triphenyltetrazolium chloride

Notes

Acknowledgements

Funded by The Danish Diabetes Academy and supported by the Novo Nordisk Foundation (NNF17OC0028766) and The Health Research Fund of Central Denmark Region, Denmark.

References

  1. 1.
    Botker HE et al (2012) Measuring myocardial salvage. Cardiovasc Res 94(2):266–275CrossRefGoogle Scholar
  2. 2.
    Croisille P, Kim HW, Kim RJ (2012) Controversies in cardiovascular MR imaging: T2-weighted imaging should not be used to delineate the area at risk in ischemic myocardial injury. Radiology 265(1):12–22CrossRefGoogle Scholar
  3. 3.
    Kim HW et al (2015) Relationship of T2-weighted MRI myocardial hyperintensity and the ischemic area-at-risk. Circ Res 117(3):254–265CrossRefGoogle Scholar
  4. 4.
    Hansen ES et al (2016) Cardiovascular MR T2-STIR imaging does not discriminate between intramyocardial haemorrhage and microvascular obstruction during the subacute phase of a reperfused myocardial infarction. Open Heart 3(1):e000346CrossRefGoogle Scholar
  5. 5.
    Fernandez-Jimenez R et al (2015) Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: imaging and histological tissue characterization. J Am Coll Cardiol 65(4):315–323CrossRefGoogle Scholar
  6. 6.
    Fernandez-Jimenez R et al (2017) Dynamic edematous response of the human heart to myocardial infarction: implications for assessing myocardial area at risk and salvage. Circulation 136(14):1288–1300CrossRefGoogle Scholar
  7. 7.
    Sorensson P et al (2010) Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography. J Cardiovasc Magn Reson 12:25CrossRefGoogle Scholar
  8. 8.
    Kumar A et al (2011) CMR imaging of edema in myocardial infarction using cine balanced steady-state free precession. JACC Cardiovasc Imaging 4(12):1265–1273CrossRefGoogle Scholar
  9. 9.
    Hammer-Hansen S et al (2017) Early gadolinium enhancement for determination of area at risk: a preclinical validation study. JACC Cardiovasc Imaging 10(2):130–139CrossRefGoogle Scholar
  10. 10.
    Nordlund D et al (2017) Experimental validation of contrast-enhanced SSFP cine CMR for quantification of myocardium at risk in acute myocardial infarction. J Cardiovasc Magn Reson 19(1):12CrossRefGoogle Scholar
  11. 11.
    Pedersen SF et al (2015) Dimethyl sulfoxide reduces microvascular obstruction and intramyocardial hemorrhage in a porcine ischemia–reperfusion model. Heart Res Open J 2(2):85–91CrossRefGoogle Scholar
  12. 12.
    Tufvesson J et al (2016) Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT. BMC Med Imaging 16:19CrossRefGoogle Scholar
  13. 13.
    Sjogren J et al (2012) Semi-automatic segmentation of myocardium at risk in T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14:10CrossRefGoogle Scholar
  14. 14.
    Heiberg E et al (2008) Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. Radiology 246(2):581–588CrossRefGoogle Scholar
  15. 15.
    Reeder SB, Herzka DA, McVeigh ER (2004) Signal-to-noise ratio behavior of steady-state free precession. Magn Reson Med 52(1):123–130CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.The MR Research Centre and Department of Clinical MedicineAarhus University Hospital SkejbyAarhus NDenmark
  2. 2.Danish Diabetes AcademyOdenseDenmark
  3. 3.Department of Cardiothoracic and Vascular Surgery TAarhus University Hospital SkejbyAarhus NDenmark
  4. 4.Department of Endocrinology and Internal MedicineAarhus University Hospital THGAarhus CDenmark
  5. 5.Department of CardiologyAarhus University Hospital SkejbyAarhus NDenmark

Personalised recommendations